Autonomix Medical, Inc.

Quarterly Report for period ending 2023-12-31

Semiannual Report Pursuant to Regulation A for period ending 2023-09-30

Current report filing

Certification by an exchange approving securities for listing

Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)

Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular

None

Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular

Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular

None

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Exempt (Private) Offering

KLEMP WALTER V: Major Shareholders

BioStar Ventures III, L.P.: Initial statement of beneficial ownership of securities

Robins David Andrew: Initial statement of beneficial ownership of securities

KLEMP WALTER V: Initial statement of beneficial ownership of securities

Foster Jonathan P.: Initial statement of beneficial ownership of securities

Capelli Christopher: Initial statement of beneficial ownership of securities

Smith Trent N.: Initial statement of beneficial ownership of securities

Bisson Lori: Initial statement of beneficial ownership of securities

Post-qualification amendment to a 1-A offering statement

Offering statement under Regulation A

Offering statement under Regulation A

Offering statement under Regulation A

Offering statement under Regulation A